文献速递鼻科

Medicare中鼻窦球囊导管扩张术的报销趋势与高频手术医生分析

Medicare Reimbursement for Balloon Catheter Dilations Among Surgeons Performing High Volumes of the Procedures to Treat Chronic Rhinosinusitis.
PubMed 文献 · JAMA Otolaryngol Head Neck Surg · 2020-01-01

高频手术的耳鼻咽喉科医生数量从2012年101人增至2016年382人,2016年60.1%的BCD由高频医生完成。

要点

  • BCD手术量及报销额在2011至2017年间均大幅增长。
  • 高频BCD手术的耳鼻咽喉科医生数量及手术占比显著上升。
  • 2016年60.1%的BCD由年手术量>10例的高频医生完成。

核心结论

  • BCD在治疗慢性鼻窦炎的耳鼻咽喉科医生中持续普及。
  • 大多数BCD由高频手术的耳鼻咽喉科医生完成。

研究设计与样本

  • 回顾性分析2011至2017年Medicare Part B国家摘要数据文件及提供者利用与支付数据。
  • 纳入接受BCD手术(CPT代码31295、31296、31297)的患者。

主要发现

  • 高频手术的耳鼻咽喉科医生从2012年101人增至2016年382人(增长270%)。
  • 最佳拟合线显示,第75百分位手术量医生每年中位手术量增加4.2例BCD,第50百分位增加1.5例。

关键数值与推荐

  • 高频手术定义为每年BCD手术量>10例。
  • BCD手术包括上颌窦扩张(31295)、额窦扩张(31296)和蝶窦扩张(31297)。

临床怎么用

  • BCD作为慢性鼻窦炎手术治疗的选择在Medicare人群中日益普遍。
  • 报销趋势和手术量分布可为临床实践和医疗政策提供参考。

局限性

  • 研究为回顾性设计,仅基于Medicare报销数据。
  • 未纳入非Medicare人群及未报销手术。
  • 高频医生定义阈值(>10例/年)可能影响分组结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Chronic rhinosinusitis is among the most common and costly conditions treated by physicians. After failure of medical treatment, surgical intervention in the form of endoscopic sinus surgery is traditionally offered. Balloon catheter dilation (BCD) has become a less-invasive alternative with increasing popularity among otolaryngologists. OBJECTIVE: To evaluate the most recent BCD data in the Medicare population, with a specific focus on the percentage of procedures performed by surgeons who perform high volumes of this procedure, their reimbursements, and their national geographic distributions. DESIGN, SETTING, AND PARTICIPANTS: This retrospective review included data from 2011 through 2017 from Medicare Part B National Summary Data Files and Medicare Provider Utilization and Payment Data. Patients with procedures including Current Procedural Terminology codes 31295 (maxillary sinus dilation), 31296 (frontal sinus dilation), and 31297 (sphenoid sinus dilation) were included. EXPOSURES: Balloon catheter dilation of the paranasal sinuses. MAIN OUTCOMES AND MEASURES: Total and mean reimbursements over time to physicians for BCDs, as well as the percentage of BCDs performed by and reimbursed to ear, nose, and throat (ENT) surgeons who perform high volumes of BCDs (>10 procedures) in a given year. RESULTS: The total number of BCDs rose from 7496 in 2011 to 43 936 in 2017 (a 486% increase). The overall reimbursement increased from $11 773 049 in 2011 to $63 927 591 in 2017 (a 433% increase). From 2012 to 2016, ENT surgeons who performed high volumes of the procedures rose from 101 to 382 surgeons (a 270% increase). In 2016, 25 214 of 41 960 BCDs (60.1%) were performed by ENT surgeons performing high volumes of the procedure, compared with 5603 of 13 109 procedures (42.7%) in 2012. In a line of best fit, at the 75th percentile of procedure volume, there was an increase of 4.2 BCDs in the median number of procedures done per physician per year, compared with an increase of 1.5 BCD procedures per physician per year in the line of best fit for the 50th percentile. CONCLUSIONS AND RELEVANCE: Balloon catheter dilation continues to increase in popularity among otolaryngologists treating chronic rhinosinusitis. Most BCDs are performed by ENT surgeons who perform high volumes of the procedure.

来源:JAMA Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Kasle DA, Torabi SJ, Narwani V, et al. Medicare Reimbursement for Balloon Catheter Dilations Among Surgeons Performing High Volumes of the Procedures to Treat Chronic Rhinosinusitis. JAMA Otolaryngol Head Neck Surg. 2020. PMID: 31971549. doi:10.1001/jamaoto.2019.4357

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。